A randomized trial comparing vascular access strategies for patients receiving chemotherapy with trastuzumab for early-stage breast cancer-Reference-Cited by-同舟云学术

A randomized trial comparing vascular access strategies for patients receiving chemotherapy with trastuzumab for early-stage breast cancer

Published:2020-01-30 Issue:10 Volume:28 Page:4891-4899
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Clemons Mark^ORCID,Stober Carol,Kehoe Anne,Bedard Debbie,MacDonald Fiona,Brunet Marie-Claude,Saunders Deanna,Vandermeer Lisa,Mazzarello Sasha,Awan Arif,Basulaiman Bassam,Robinson Andrew,Mallick Ranjeeta,Hutton Brian,Fergusson Dean

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-020-05326-y.pdf

Reference22 articles.

1. Lipitz-Snyderman A et al (2015) Complications associated with use of long-term central venous catheters among commercially insured women with breast cancer. J Oncol Pract 11(6):505–510

2. Chopra V, Anand S, Hickner A, Buist M, Rogers MA, Saint S, Flanders SA (2013) Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet 382(9889):311–325

3. LeVasseur N, Stober C, Daigle K, Robinson A, McDiarmid S, Mazzarello S, Hutton B, Joy A, Fergusson D, Hilton J, McInnes M, Clemons M (2018) Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer-a survey of oncology nurses and physicians. Curr Oncol 25(4):e298–e304

4. LeVasseur N, Stober C, Ibrahim M, Gertler S, Hilton J, Robinson A, McDiarmid S, Fergusson D, Mazzarello S, Hutton B, Joy AA, McInnes M, Clemons M (2018) Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer—a patient survey. Curr Oncol 25(4):e305–e310

5. Krein SL et al (2019) Patient-reported complications related to peripherally inserted central catheters: a multicentre prospective cohort study. BMJ Qual Saf 28(7):574–581

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular access device type for systemic anti-cancer therapies in cancer patients: A scoping review;Critical Reviews in Oncology/Hematology;2024-04

2. Scarless totally implantable venous access port (TIVAP) implantation: Surgical technique, preliminary results, learning curve, and patients-reported outcome in 125 breast cancer patients;Surgical Oncology;2024-04

3. Effect of Two Different Catheter Dressings on Pain, Comfort, and Satisfaction in Chemotherapy Patients: A Randomized Controlled Study;Florence Nightingale Journal of Nursing;2024-02-28

4. Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective;Current Oncology;2023-12-14

5. Clinical characteristics of peripherally inserted central catheter-related complications in cancer patients undergoing chemotherapy: a prospective and observational study;BMC Cancer;2023-09-22